KLK3 and Familial prostate cancer: Our cases suggest that, in adenocarcinoma of the prostate, the appearance of new or enlarging lymphadenopathy or new bony lesions cannot be assumed to solely represent progression of the prostate cancer and warrants further investigation especially in the presence of stable PSA levels.